Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers

The adjuvant treatment landscape for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) early breast cancer (EBC) is rapidly evolving, with a diverse range of therapeutic options—including endocrine therapies, bisphosphonates, ovarian function suppression, ola...

Full description

Saved in:

Bibliographic Details
Main Authors:	Angela Chan, Nancy Nixon, Muna Al-Khaifi, Alain Bestavros, Christine Blyth, Winson Y. Cheung, Caroline Hamm, Thomas Joly-Mischlich, Mita Manna, Tom McFarlane, Laura V. Minard, Sarah Naujokaitis, Christine Peragine, Cindy Railton, Scott Edwards
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Current Oncology
Subjects:	CDK4/6 inhibitors early breast cancer HR+, HER2– multidisciplinary care models team-based care pharmacist-led care
Online Access:	https://www.mdpi.com/1718-7729/32/7/402
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers

Similar Items